Baybio Pac, Sponsored By the Bay Area Bioscience Association

View

Source Type	Amount	Percentage
Other	$200K	89.6%
Individual	$19.8K	8.8%
Committee	$3.53K	1.6%
Total	$223K	100%

Itemized Group by Donor

Donor	Total Amount	% of Total
Onyx Pharmaceuticals via Baybio Other	~$X,XXX	1.1%
Intermune, Inc. Other	~$X,XXX	1.1%
Sunovion Other	~$X,XXX	1.0%
Paul J. Hastings Chief Executive Officer at Oncomed Pharmaceuticals	~$X,XXX	0.9%
David Martin Physician at Avid Biotics Corp.	~$X,XXX	0.9%
Allergan Usa, Inc. Other	~$X,XXX	0.9%
Sunovion Pharmaceuticals via Baybio Other	~$X,XXX	0.9%
Peter Daly Executive at Wells Fargo Insurance Services	~$X,XXX	0.9%
Boehringer-Ingelheim Pharm via Baybio Other	~$X,XXX	0.9%
Bay Area Bioscience Association (Baybio) Other	~$X,XXX	0.7%
Gail J. Maderis Chief Executive Officer at Five Prime Therapeutics	~$X,XXX	0.7%
Monogram Biosciences Other	~$X,XXX	0.6%
Proteolix Inc. Other	~$X,XXX	0.5%
The Lodge at Tiburon Other	~$X,XXX	0.5%
Gregg Alton Executive Vice President at Gilead Sciences, Inc.	~$X,XXX	0.4%
Alan Mendelson Attorney at Latham & Watkins Llp	~$X,XXX	0.4%
Svb Financial Group Other	~$X,XXX	0.4%
Ucb, Inc. Via Baybio Other	~$X,XXX	0.4%
William D. Young Executive at Monogram Biosciences	~$X,XXX	0.4%
Scott Morrison Us Life Sciences Director at Ernst & Young, Llp	~$X,XXX	0.4%
Eisai Inc. Via Baybio Other	~$X,XXX	0.4%
Genomic Health via Baybio Other	~$X,XXX	0.4%
Onyx Pharmaceuticals (Via Baybio Assn.) Other	~$X,XXX	0.4%
Matthew Gardner President at Bay Area Bioscience Association	~$X,XXX	0.4%
Anthony J. Stolis Consultant at Clarkston Consulting	~$X,XXX	0.4%

Page 2 of 7